BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CTMSS - ECPv6.7.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://clinicaltmssociety.org
X-WR-CALDESC:Events for CTMSS
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20240305T080000
DTEND;TZID=UTC:20240305T210000
DTSTAMP:20260910T153657
CREATED:20241017T011402Z
LAST-MODIFIED:20260506T160439Z
UID:1189-1709625600-1709672400@clinicaltmssociety.org
SUMMARY:Research and Clinical Applications of TMS in Pediatric and Neurodevelopmental Populations
DESCRIPTION:> > Register Now <<\nThe CDC currently estimates that nearly 1 in 5 children have a developmental or psychiatric disorder; yet evidence-based\, targeted treatments for these disorders are lacking. \nTaking an Experimental Therapeutics approach\, the research that will be discussed aims to understand the mechanisms that contribute to dysfunctional development of neural systems associated with symptoms of pediatric psychiatric and neurodevelopmental disorders utilizing neuroimaging and neurophysiological tools combined with transcranial magnetic stimulation interventions. The ultimate goal of the research that will be discussed is to inform the development of novel targeted device-based treatment strategies. Though there is much promise for these targeted device-based interventions\, data on the safety and efficacy of these interventions in pediatric and neurodevelopmental populations is limited. The current state of the research will be reviewed and future directions for the field will be discussed. \nAt the end of this presentation participants will be able to: \n\nReview the findings of studies using TMS to probe physiology in autism spectrum disorder (ASD).\nDescribe how TMS can be used to induce long-term changes in brain network functioning and potentially treat pediatric neuropsychiatric and behavioral disorders.\nIdentify potential network targets where applying TMS may be effective for reducing transdiagnostic symptom domains commonly seen in neuropsychiatric and behavioral disorders.\n\n1 Hour CME Credit Available \nFormat: Live Webinar \nCost: Members: $25 | Non-members $50 | Student Members FREE \n\nSpeaker: Lindsay Oberman\, PhD \n \nDr. Lindsay Oberman received her PhD from UCSD in Experimental Psychology in 2007. Since that time\, she has published over 60 peer-reviewed articles. She has gained international attention for pioneering the use of Repetitive Transcranial Magnetic Stimulation (rTMS) in complex neurodevelopmental and neuropsychiatric disorders including autism\, mood disorders\, and traumatic brain injury. Dr. Oberman’s research involves the use of an experimental therapeutics approach applying neuroimaging and neurophysiological measures to identify dysfunctional neural circuitry associated with specific transdiagnostic behavioral domains such as mood regulation\, sensory processing\, social cognition\, and executive functioning across disorders. In doing so\, she is able to develop novel individualized rTMS treatment protocols that are informed by functional brain network organization. She is currently a Staff Scientist and Directs the Developmental Clinical Neurophysiology and Neurostimulation Research Program within the National Institute of Mental Health Intramural Research Program. \n> > Register Now <<
URL:https://clinicaltmssociety.org/event/research-and-clinical-applications-of-tms-in-pediatric-and-neurodevelopmental-populations-2/
CATEGORIES:All Events,Grand Rounds Webinar
END:VEVENT
END:VCALENDAR